A61K 31/7056
Containing five-membered rings with nitrogen as a ring hetero atom
Official title: containing five-membered rings with nitrogen as a ring hetero atom
A61K31/7056 (Containing five-membered rings with nitrogen as a ring hetero atom) appears on 919 US grants and 1,805 published applications in this corpus.
Search patents in A61K- Granted patents
- 919
- Published applications
- 1,805
- Assignees
- 767
- Inventors
- 3,141
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 7 | 0 |
| 1999 | 1 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 1 |
| 2002 | 8 | 25 |
| 2003 | 6 | 26 |
| 2004 | 15 | 42 |
| 2005 | 8 | 47 |
| 2006 | 12 | 47 |
| 2007 | 19 | 53 |
| 2008 | 15 | 38 |
| 2009 | 17 | 42 |
| 2010 | 11 | 54 |
| 2011 | 20 | 97 |
| 2012 | 19 | 63 |
| 2013 | 58 | 134 |
| 2014 | 85 | 131 |
| 2015 | 61 | 114 |
| 2016 | 73 | 116 |
| 2017 | 70 | 103 |
| 2018 | 51 | 69 |
| 2019 | 53 | 76 |
| 2020 | 46 | 84 |
| 2021 | 55 | 96 |
| 2022 | 38 | 82 |
| 2023 | 45 | 82 |
| 2024 | 35 | 74 |
| 2025 | 34 | 56 |
| 2026 | 29 | 53 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aqueous pharmaceutical compositions comprising SGLT-2 inhibitors29 Sep 2026US 12,746,198 B2
- Imidazole-based synthetic lipidoids for in vivo mRNA delivery into immune cells29 Sep 2026US 12,747,214 B2Trustees of Tufts College
- Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways15 Sep 2026US 12,734,189 B2Northwestern University
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Hexahydro[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine deuterated derivative, pharmaceutical composition thereof, preparation method therefor, and anti-influenza use thereof8 Oct 2026US 2026/0308174 A1Changsha Jingyi Pharmaceutical Technology Co., Ltd
- Helicase inhibitors8 Oct 2026US 2026/0308196 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Methods for weight loss and/or reducing weight gain1 Oct 2026US 2026/0294867 A1The Medical College of Wisconsin, Inc.
- Adenosine analog and its use in regulating the circadian clock1 Oct 2026US 2026/0294952 A1National Institute of Biological Sciences, Beijing
Most cited
By later US patents
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase223US 7,125,855 B2Merck & Co., Inc. · 2006
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus217US 6,777,395 B2Isis Pharmaceuticals, Inc. · 2004
- Prodrugs phosphorus-containing compounds200US 6,312,662 B1Metabasis Therapeutics, Inc. · 2001
- Methods and compositions for treating flaviviruses and pestiviruses187US 7,105,493 B2Idenix Pharmaceuticals, Inc. · 2006